Developer docs
API playgroundTry for free, no card

Search company profiles

Qwince

Full company profile

uuid00247nn

Namestring
Qwince
Legal namestring
QWINCE Innovation S.R.L.
Websiteurl
qwince.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Qwince is an Italian healthcare technology company headquartered in Palermo (operating as QWINCE Innovation S.r.l., formerly Securproject.it) that has been active since 2013, building an integrated platform for patient care management, telemedicine, and Real World Evidence generation. Its product portfolio is anchored by adam.os, a modular, interoperable operating system that orchestrates clinical pathways and unifies heterogeneous healthcare data sources using HL7/FHIR standards. Specialized products sit on top of this core: ConCura (chronic and acute patient management with teleconsultation, therapy reminders, and IoMT integration), Teleconsulto (secure video consultations), Puntofarma (qualified medical device infrastructure for care pathway orchestration), Mercurio (mass personalized messaging across PEC/SMS/WhatsApp/Telegram), and research-stage initiatives including the 3D Motion Tracker (wearable mobility assessment) and OBIND (oncology data integration and rational drug design).

The company targets four primary customer segments: pharmaceutical companies (for Real World Evidence and therapy value demonstration), pharmacies and distributors (operational and engagement tools), healthcare operators and facilities (remote monitoring, clinical decision support), and research institutions (biomedical data integration and AI-driven research). Revenue is generated through software platform subscriptions (Mercurio is publicly priced at €125/€290/€500 per month for Bronze/Silver/Gold tiers), professional services for Real World Evidence, and a ConCura Service Center offering patient triage and journey management. Go-to-market combines direct enterprise sales in Italy with channel partnerships through Promofarma, Federfarma, and Assofarm for the pharmacy ecosystem, alongside community-credibility building through EU-funded research projects (OBIND, ConCura AD-EWS under PNRR, xShare under Horizon Europe).

Qwince holds ISO 13485 medical device quality certification, is a member of the NVIDIA Inception Program, and operates with a small team of 1-10 employees. Named customers and partners include MSD (pharma), ASL Pescara and La Maddalena (healthcare providers), Brunel University London, Fondazione Ri.MED and IRIB-CNR (research), and CVBF (regulatory/clinical trials). Strategic technology partners include AiCure (AI behavioral analytics), BioBeat (IoMT wearables), Exprivia and the Università degli Studi di Palermo (oncology research consortium). The company is privately held with no disclosed equity funding rounds and reports no revenue figures; the bulk of recent activity has been financed via non-dilutive public grants.

Short descriptiontext

Qwince is an Italian healthcare technology company (headquartered in Palermo) that builds the adam.os interoperable platform plus ConCura, Puntofarma, Teleconsulto, and Mercurio products to deliver patient care management, AI clinical decision support, telemedicine, and Real World Evidence services to pharmaceutical companies, pharmacies, hospitals, and research institutions across Italy and the EU.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPalermo, Italy
HQ citystring
Palermo
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare technology platforms, clinical decision support, remote patient monitoring, real world evidence, telemedicine solutions
Industry5 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALABAI
Virtual Care Team Collaboration & Provider-to-Provider Teleconsult Platforms (eConsults)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALABAM
Revenue Cycle, Coding & Telehealth Compliance Platforms (for provider orgs)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAK
Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
NAICS code3 codes
  • Software Publishers5132
  • Software Publishers51321
  • Custom Computer Programming Services541511
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Health Services8000
Product category
Healthcare Technology Platforms
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Platform Subscriptions
TypeSubscription Recurring
Description

Qwince generates recurring revenue through subscriptions to its platforms including ConCura, Puntofarma, Teleconsulto, and adam.os, which are offered to healthcare organizations, pharmaceutical companies, and pharmacy networks.

qwince.com
2Mercurio Messaging Platform
TypeSubscription Recurring
Description

Mercurio operates on a tiered subscription model (Bronze, Silver, Gold) with different message volume limits and storage capacities, providing mass personalized messaging services for healthcare compliance communication.

mercurio.qwince.com
3Real World Evidence Services
TypeProfessional Services
Description

Qwince provides data analysis and Real World Evidence generation services to pharmaceutical partners, transforming real-world data into strategic evidence to demonstrate therapy value.

qwince.com
4Professional Healthcare Services
TypeProfessional Services
Description

The ConCura platform includes a dedicated Service Center providing pro-active organizational triage and patient guidance services for healthcare journey management.

qwince.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Bronze: 40,000 sends/year, 10 GB storage
ModelSubscriptionBilling cadenceMonthly
Notes

Bronze plan at €125/month includes up to 40,000 message sends per year and maximum 10 GB disk space.

mercurio.qwince.com
2Silver: 200,000 sends/year, 100 GB storage
ModelSubscriptionBilling cadenceMonthly
Notes

Silver plan at €290/month includes up to 200,000 message sends per year and maximum 100 GB disk space.

mercurio.qwince.com
3Gold: 2,000,000 sends/year, 1 TB storage
ModelSubscriptionBilling cadenceMonthly
Notes

Gold plan at €500/month includes up to 2,000,000 message sends per year and maximum 1 TB disk space.

mercurio.qwince.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1adam.os
Description

Healthcare operating system that integrates existing systems, unifies information flows, and enables advanced AI functions. Acts as a central 'brain' orchestrating the entire clinical pathway for healthcare operators and patient care.

qwince.com
+5 more records
Core offering1 text field

Qwince sells a modular healthcare technology ecosystem anchored by adam.os, a software operating system that integrates clinical pathways, unifies information flows, and enables AI capabilities across heterogeneous health data sources. Built on this core platform, the company offers ConCura for patient care management and teleconsultation (a qualified medical device), Teleconsulto for secure video consultations, Puntofarma for clinical coordination across clinics, hospitals, and pharmacies, and Mercurio for multi-channel healthcare-compliant mass messaging. The company also delivers professional services for Real World Evidence generation to pharmaceutical and research partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 80% of chronic patients consider digital health platforms necessary for managing their pathology (Qwince-Doxa Pharma survey, July 2023)
+2 more records
Product overview1 text field

Qwince operates as a platform-plus-modules architecture offering healthcare technology solutions. The ecosystem is anchored by adam.os, a modular healthcare operating system that orchestrates data integration and AI capabilities. This core platform connects multiple specialized products: ConCura (patient management and teleconsultation platform), Teleconsulto (secure video consultation), Puntofarma (clinical coordination infrastructure), and Mercurio (communication engine). Research initiatives include the 3D Motion Tracker for mobility assessment and Obind for oncology data analysis. The company targets pharmaceutical companies, distributors, pharmacies, healthcare operators and facilities, and research institutions to transform Real World Data into strategic evidence for evidence-based medicine.

Product and service6 records
1adam.os
CategoryHealthcare Operating System / Data Integration Platform
Description

adam.os is a modular, interoperable software operating system for healthcare that acts as a central brain, integrating existing systems, unifying information flows, and enabling advanced AI functions. It orchestrates the entire clinical pathway for healthcare operators and patient care journeys, processing data in aggregated and anonymized form across heterogeneous sources.

2ConCura
CategoryPatient Care Management / Remote Monitoring Platform
Description

ConCura is a software medical device platform for patient management and follow-up in chronic disease and acute event care. It supports appointment booking, therapy reminders, teleconsultation, and integrates with IoMT devices (e.g., BioBeat Chest Monitor) for remote monitoring of vital signs, with a dedicated human Service Center providing pro-active triage and patient guidance.

3Teleconsulto
CategoryTelemedicine / Teleconsultation Platform
Description

Teleconsulto is a secure teleconsultation platform enabling real-time video consultations between patients and healthcare providers. It integrates with adam.os to provide clinicians with comprehensive, real-time patient data from connected devices and services during consultations.

4Puntofarma
CategoryClinical Care Pathway Infrastructure
Description

Puntofarma is a qualified medical device technological infrastructure enabling clinics, hospitals, research centers, and pharmaceutical companies to securely orchestrate patient care pathways. It serves as a digital engine for complex chronic disease management, addressing process fragmentation and low therapeutic adherence.

5Mercurio
CategoryHealthcare-compliant Multi-channel Messaging Platform
Description

Mercurio is an advanced mass messaging technology for sending personalized messages to large recipient groups via PEC, SMS, WhatsApp, and Telegram with complete traceability and receipt reconciliation. It is a healthcare-compliant communication engine natively integrated within the adam.os ecosystem, offered on tiered subscriptions (Bronze €125/month up to 40k sends, Silver €290/month up to 200k sends, Gold €500/month up to 2M sends).

6Real World Evidence Generation Services
CategoryData Analytics / Real World Evidence Professional Services
Description

Professional services that transform real-world healthcare data into strategic Real World Evidence, predictive reports, and recommendations for pharmaceutical and research partners. Includes data analysis, patient engagement insights, therapy adherence modeling, and therapy value demonstration support.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeTechnology or Integration
Description

Qwince is a member of the NVIDIA Inception Program, gaining access to NVIDIA's AI, computing, and GPU technologies including RTX GPUs and BioNeMo platform for developing healthcare AI solutions such as telehealth and patient data analysis.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership to bring AiCure's AI-based predictive technology for drug development and chronic patient care to the Italian market. Qwince shares AiCure's holistic patient view for improved engagement and behavioral data quality.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on xShare project (Horizon Europe) to demonstrate how ConCura can apply European Health Data Space (EHDS) standards for secondary health data research, enabling secure identification of patients eligible for clinical trials.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration on Major Project DM3306 to develop user experience and gesture input for THALMIC LABS MYO technology for elderly and disabled persons with low mobility. Qwince developed a mobile app prototype for activity level assessment.

5La Maddalena S.p.A. – Dipartimento Oncologico di 3° Livello
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research partner for ConCura AD-EWS project, focusing on cardiotoxicity monitoring in oncology patients during and after chemotherapy treatment using BioBeat Chest Monitor devices.

qwince.com
6Clinica Ruesch di Napoli (Gruppo GVM)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner for ConCura ADSF project, implementing AI-based decision support to predict deterioration in frailty levels among chronic and elderly patients managed at home, using BioBeat Chest Monitor devices.

qwince.com
7Exprivia S.p.A.
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Lead partner in the OBIND project, working with Qwince Innovation to develop an expert system integrating medicinal chemistry and transcriptomics/proteomics data for rational drug design in oncology.

qwince.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research partner in OBIND project through multiple departments: Dipartimento di Ingegneria dell'Innovazione Industriale e Digitale (DIID), Dipartimento di Scienze Economiche Aziendali e Statistiche (DSEAS), Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), and Centro ATeN.

9Fondazione Ri.MED
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research partner in OBIND oncological research project, contributing to the development of systems for aggregating and analyzing heterogeneous cancer research datasets.

qwince.com
10OS2 S.R.L.
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Project partner in OBIND oncological research initiative.

qwince.com
112038 Innovation Company
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Project partner in OBIND oncological research initiative.

qwince.com
12IRIB-CNR (Istituto Per La Ricerca e l'Innovazione Biomedica)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research partner in OBIND project, contributing expertise in biomedicine and molecular immunology for oncological data integration research.

qwince.com
Strategic tierCoreTypeTechnology or Integration
Description

Provider of innovative 'Chest Monitor' devices for vital sign detection and remote patient monitoring, used in ConCura AD-EWS and ADSF projects for real-time health data collection.

14BVA Doxa Pharma
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaboration for patient chronic disease survey on digital health adoption, published July 2023, providing market insights into patient attitudes toward healthcare technology.

qwince.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

E-commerce platform partnership (marketplace.promofarma.it) offering innovative technological solutions for Federfarma-associated pharmacies in Italy, including digital invoicing, medical devices, and patient adherence tools.

16DAFNE Consortium
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration on pharmaceutical document digitization project, working with PromoFarma, Federfarma, and Assofarm to implement full digitization of delivery documents, digital archiving, and electronic invoice matching.

qwince.com
17Assofarm
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Collaboration on pharmaceutical document digitization solutions alongside DAFNE Consortium, PromoFarma, and Federfarma for Italian pharmacy network digital transformation.

qwince.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Doctolib
TypeBroad incumbent
Description

Leading European telehealth and practice-management platform operating in Italy and France, offering online booking, teleconsultation, and patient management — comparable to Qwince's ConCura and Teleconsulto modules but at much larger scale and broader scope.

TypeDirect peer
Description

US-based AI patient monitoring and adherence platform for clinical trials and chronic care — already a strategic partner of Qwince and directly comparable in AI behavioral analytics and patient adherence prediction.

TypeDirect peer
Description

UK virtual ward and remote patient monitoring provider serving hospitals with continuous vital sign monitoring — comparable to Qwince's BioBeat-integrated ConCura AD-EWS/ADSF modules for chronic and elderly patients.

4Exprivia
TypeRegional player
Description

Italian IT services and healthcare technology vendor, partner of Qwince in OBIND — comparable as a domestic health-IT player providing software platforms and clinical decision support to Italian healthcare organizations.

TypeDirect peer
Description

Dutch remote patient monitoring and virtual care platform used across European hospitals for chronic disease and post-discharge monitoring — closely comparable to ConCura's chronic care and teleconsultation capabilities.

TypeDirect peer
Description

UK-based digital health platform combining RPM, patient engagement, and AI-driven predictive analytics for hospitals and pharma — directly comparable to Qwince's adam.os + ConCura + AD-EWS stack.

TypeBroad incumbent
Description

Global telehealth and virtual care platform offering chronic condition management, RPM, and provider-to-provider consultations — a broad incumbent illustrating the scale Qwince's Teleconsulto and ConCura compete against.

TypeBroad incumbent
Description

Online healthcare booking and practice management platform with a major presence in Italy via MioDottore, including telemedicine features — overlaps with Qwince's Teleconsulto and Puntofarma offerings in the Italian provider ecosystem.

TypeRegional player
Description

Swiss telemedicine and digital health platform offering 24/7 teleconsultations and chronic care programs — a European regional peer comparable in teleconsultation and chronic disease management scope.

TypeRegional player
Description

Italian digital health consultancy and technology company serving pharma and providers with digital therapeutics and engagement solutions — comparable to Qwince's pharmaceutical RWE and patient engagement focus in the Italian market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qwince

Healthcare Technology Platformsqwince.com

Qwince is an Italian healthcare technology company (headquartered in Palermo) that builds the adam.os interoperable platform plus ConCura, Puntofarma, Teleconsulto, and Mercurio products to deliver patient care management, AI clinical decision support, telemedicine, and Real World Evidence services to pharmaceutical companies, pharmacies, hospitals, and research institutions across Italy and the EU.

What Qwince does

Qwince is an Italian healthcare technology company headquartered in Palermo (operating as QWINCE Innovation S.r.l., formerly Securproject.it) that has been active since 2013, building an integrated platform for patient care management, telemedicine, and Real World Evidence generation. Its product portfolio is anchored by adam.os, a modular, interoperable operating system that orchestrates clinical pathways and unifies heterogeneous healthcare data sources using HL7/FHIR standards. Specialized products sit on top of this core: ConCura (chronic and acute patient management with teleconsultation, therapy reminders, and IoMT integration), Teleconsulto (secure video consultations), Puntofarma (qualified medical device infrastructure for care pathway orchestration), Mercurio (mass personalized messaging across PEC/SMS/WhatsApp/Telegram), and research-stage initiatives including the 3D Motion Tracker (wearable mobility assessment) and OBIND (oncology data integration and rational drug design).

The company targets four primary customer segments: pharmaceutical companies (for Real World Evidence and therapy value demonstration), pharmacies and distributors (operational and engagement tools), healthcare operators and facilities (remote monitoring, clinical decision support), and research institutions (biomedical data integration and AI-driven research). Revenue is generated through software platform subscriptions (Mercurio is publicly priced at €125/€290/€500 per month for Bronze/Silver/Gold tiers), professional services for Real World Evidence, and a ConCura Service Center offering patient triage and journey management. Go-to-market combines direct enterprise sales in Italy with channel partnerships through Promofarma, Federfarma, and Assofarm for the pharmacy ecosystem, alongside community-credibility building through EU-funded research projects (OBIND, ConCura AD-EWS under PNRR, xShare under Horizon Europe).

Qwince holds ISO 13485 medical device quality certification, is a member of the NVIDIA Inception Program, and operates with a small team of 1-10 employees. Named customers and partners include MSD (pharma), ASL Pescara and La Maddalena (healthcare providers), Brunel University London, Fondazione Ri.MED and IRIB-CNR (research), and CVBF (regulatory/clinical trials). Strategic technology partners include AiCure (AI behavioral analytics), BioBeat (IoMT wearables), Exprivia and the Università degli Studi di Palermo (oncology research consortium). The company is privately held with no disclosed equity funding rounds and reports no revenue figures; the bulk of recent activity has been financed via non-dilutive public grants.

Qwince firmographics

Firmographics
Name
Qwince
Legal name
QWINCE Innovation S.R.L.
Website
https://qwince.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Qwince is an Italian healthcare technology company (headquartered in Palermo) that builds the adam.os interoperable platform plus ConCura, Puntofarma, Teleconsulto, and Mercurio products to deliver patient care management, AI clinical decision support, telemedicine, and Real World Evidence services to pharmaceutical companies, pharmacies, hospitals, and research institutions across Italy and the EU.
Ownership category
akta.pro rank

Qwince industry classification

Industry
Product category
Healthcare Technology Platforms
NAICS
Software Publishers (5132), Software Publishers (51321), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALABAI
Virtual Care Team Collaboration & Provider-to-Provider Teleconsult Platforms (eConsults)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALABAM
Revenue Cycle, Coding & Telehealth Compliance Platforms (for provider orgs)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAK
Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms

Keywords

  • Healthcare technology platforms
  • Clinical decision support
  • Remote patient monitoring
  • Real world evidence
  • Telemedicine solutions

Where Qwince is headquartered

Location

Headquarters

HQ city
Palermo
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Qwince business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Platform Subscriptions: Qwince generates recurring revenue through subscriptions to its platforms including ConCura, Puntofarma, Teleconsulto, and adam.os, which are offered to healthcare organizations, pharmaceutical companies, and pharmacy networks.
  2. Mercurio Messaging Platform: Mercurio operates on a tiered subscription model (Bronze, Silver, Gold) with different message volume limits and storage capacities, providing mass personalized messaging services for healthcare compliance communication.
  3. Real World Evidence Services: Qwince provides data analysis and Real World Evidence generation services to pharmaceutical partners, transforming real-world data into strategic evidence to demonstrate therapy value.
  4. Professional Healthcare Services: The ConCura platform includes a dedicated Service Center providing pro-active organizational triage and patient guidance services for healthcare journey management.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyBronze: 40,000 sends/year, 10 GB storage
SubscriptionMonthlySilver: 200,000 sends/year, 100 GB storage
SubscriptionMonthlyGold: 2,000,000 sends/year, 1 TB storage

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Qwince product offering

Product offering

Core offering

Qwince sells a modular healthcare technology ecosystem anchored by adam.os, a software operating system that integrates clinical pathways, unifies information flows, and enables AI capabilities across heterogeneous health data sources. Built on this core platform, the company offers ConCura for patient care management and teleconsultation (a qualified medical device), Teleconsulto for secure video consultations, Puntofarma for clinical coordination across clinics, hospitals, and pharmacies, and Mercurio for multi-channel healthcare-compliant mass messaging. The company also delivers professional services for Real World Evidence generation to pharmaceutical and research partners.

Product overview

Qwince operates as a platform-plus-modules architecture offering healthcare technology solutions. The ecosystem is anchored by adam.os, a modular healthcare operating system that orchestrates data integration and AI capabilities. This core platform connects multiple specialized products: ConCura (patient management and teleconsultation platform), Teleconsulto (secure video consultation), Puntofarma (clinical coordination infrastructure), and Mercurio (communication engine). Research initiatives include the 3D Motion Tracker for mobility assessment and Obind for oncology data analysis. The company targets pharmaceutical companies, distributors, pharmacies, healthcare operators and facilities, and research institutions to transform Real World Data into strategic evidence for evidence-based medicine.

Differentiator

Problem solved

Functional benefit

Brands

  • adam.os: Healthcare operating system that integrates existing systems, unifies information flows, and enables advanced AI functions. Acts as a central 'brain' orchestrating the entire clinical pathway for healthcare operators and patient care.
  • ConCura
  • Teleconsulto
  • Puntofarma
  • Mercurio
  • Neuralya

Products and services

  • adam.os adam.os is a modular, interoperable software operating system for healthcare that acts as a central brain, integrating existing systems, unifying information flows, and enabling advanced AI functions. It orchestrates the entire clinical pathway for healthcare operators and patient care journeys, processing data in aggregated and anonymized form across heterogeneous sources.
  • ConCura ConCura is a software medical device platform for patient management and follow-up in chronic disease and acute event care. It supports appointment booking, therapy reminders, teleconsultation, and integrates with IoMT devices (e.g., BioBeat Chest Monitor) for remote monitoring of vital signs, with a dedicated human Service Center providing pro-active triage and patient guidance.
  • Teleconsulto Teleconsulto is a secure teleconsultation platform enabling real-time video consultations between patients and healthcare providers. It integrates with adam.os to provide clinicians with comprehensive, real-time patient data from connected devices and services during consultations.
  • Puntofarma Puntofarma is a qualified medical device technological infrastructure enabling clinics, hospitals, research centers, and pharmaceutical companies to securely orchestrate patient care pathways. It serves as a digital engine for complex chronic disease management, addressing process fragmentation and low therapeutic adherence.
  • Mercurio Mercurio is an advanced mass messaging technology for sending personalized messages to large recipient groups via PEC, SMS, WhatsApp, and Telegram with complete traceability and receipt reconciliation. It is a healthcare-compliant communication engine natively integrated within the adam.os ecosystem, offered on tiered subscriptions (Bronze €125/month up to 40k sends, Silver €290/month up to 200k sends, Gold €500/month up to 2M sends).
  • Real World Evidence Generation Services Professional services that transform real-world healthcare data into strategic Real World Evidence, predictive reports, and recommendations for pharmaceutical and research partners. Includes data analysis, patient engagement insights, therapy adherence modeling, and therapy value demonstration support.

Quantifiable outcome

  • 80% of chronic patients consider digital health platforms necessary for managing their pathology (Qwince-Doxa Pharma survey, July 2023)
  • +2 more outcomes

Companies that use Qwince

Customer profile

Named customers9 records

Segments6 records

Ideal customer profiles4 records

Qwince technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature10 records

Qwince partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core, major and minor.

  • NVIDIAcoreTechnology or IntegrationQwince is a member of the NVIDIA Inception Program, gaining access to NVIDIA's AI, computing, and GPU technologies including RTX GPUs and BioNeMo platform for developing healthcare AI solutions such as telehealth and patient data analysis.
  • AiCurecoreStrategic or Co-development PartnerStrategic partnership to bring AiCure's AI-based predictive technology for drug development and chronic patient care to the Italian market. Qwince shares AiCure's holistic patient view for improved engagement and behavioral data quality.
  • CVBF (Consorzio per Valutazioni Biologiche e Farmacologiche)coreStrategic or Co-development PartnerCollaboration on xShare project (Horizon Europe) to demonstrate how ConCura can apply European Health Data Space (EHDS) standards for secondary health data research, enabling secure identification of patients eligible for clinical trials.
  • Brunel University LondoncoreStrategic or Co-development PartnerResearch collaboration on Major Project DM3306 to develop user experience and gesture input for THALMIC LABS MYO technology for elderly and disabled persons with low mobility. Qwince developed a mobile app prototype for activity level assessment.
  • La Maddalena S.p.A. – Dipartimento Oncologico di 3° LivellocoreStrategic or Co-development PartnerClinical research partner for ConCura AD-EWS project, focusing on cardiotoxicity monitoring in oncology patients during and after chemotherapy treatment using BioBeat Chest Monitor devices.
  • Clinica Ruesch di Napoli (Gruppo GVM)coreStrategic or Co-development PartnerClinical partner for ConCura ADSF project, implementing AI-based decision support to predict deterioration in frailty levels among chronic and elderly patients managed at home, using BioBeat Chest Monitor devices.
  • Exprivia S.p.A.majorStrategic or Co-development PartnerLead partner in the OBIND project, working with Qwince Innovation to develop an expert system integrating medicinal chemistry and transcriptomics/proteomics data for rational drug design in oncology.
  • Università degli Studi di Palermo (UNIPA)majorStrategic or Co-development PartnerResearch partner in OBIND project through multiple departments: Dipartimento di Ingegneria dell'Innovazione Industriale e Digitale (DIID), Dipartimento di Scienze Economiche Aziendali e Statistiche (DSEAS), Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), and Centro ATeN.
  • Fondazione Ri.MEDmajorStrategic or Co-development PartnerResearch partner in OBIND oncological research project, contributing to the development of systems for aggregating and analyzing heterogeneous cancer research datasets.
  • OS2 S.R.L.minorStrategic or Co-development PartnerProject partner in OBIND oncological research initiative.
  • 2038 Innovation CompanyminorStrategic or Co-development PartnerProject partner in OBIND oncological research initiative.
  • IRIB-CNR (Istituto Per La Ricerca e l'Innovazione Biomedica)majorStrategic or Co-development PartnerResearch partner in OBIND project, contributing expertise in biomedicine and molecular immunology for oncological data integration research.
  • BioBeatcoreTechnology or IntegrationProvider of innovative 'Chest Monitor' devices for vital sign detection and remote patient monitoring, used in ConCura AD-EWS and ADSF projects for real-time health data collection.
  • BVA Doxa PharmaminorStrategic or Co-development PartnerResearch collaboration for patient chronic disease survey on digital health adoption, published July 2023, providing market insights into patient attitudes toward healthcare technology.
  • Promofarma / FederfarmacoreChannel Partner/ Reseller/ DistributorE-commerce platform partnership (marketplace.promofarma.it) offering innovative technological solutions for Federfarma-associated pharmacies in Italy, including digital invoicing, medical devices, and patient adherence tools.
  • DAFNE ConsortiumminorStrategic or Co-development PartnerCollaboration on pharmaceutical document digitization project, working with PromoFarma, Federfarma, and Assofarm to implement full digitization of delivery documents, digital archiving, and electronic invoice matching.
  • AssofarmminorChannel Partner/ Reseller/ DistributorCollaboration on pharmaceutical document digitization solutions alongside DAFNE Consortium, PromoFarma, and Federfarma for Italian pharmacy network digital transformation.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Qwince competitors and assessment

Company assessment

Broad incumbents

  • Doctolib: Leading European telehealth and practice-management platform operating in Italy and France, offering online booking, teleconsultation, and patient management — comparable to Qwince's ConCura and Teleconsulto modules but at much larger scale and broader scope.
  • Teladoc Health: Global telehealth and virtual care platform offering chronic condition management, RPM, and provider-to-provider consultations — a broad incumbent illustrating the scale Qwince's Teleconsulto and ConCura compete against.
  • Docplanner / MioDottore: Online healthcare booking and practice management platform with a major presence in Italy via MioDottore, including telemedicine features — overlaps with Qwince's Teleconsulto and Puntofarma offerings in the Italian provider ecosystem.

Direct peers

  • AiCure: US-based AI patient monitoring and adherence platform for clinical trials and chronic care — already a strategic partner of Qwince and directly comparable in AI behavioral analytics and patient adherence prediction.
  • Doccla: UK virtual ward and remote patient monitoring provider serving hospitals with continuous vital sign monitoring — comparable to Qwince's BioBeat-integrated ConCura AD-EWS/ADSF modules for chronic and elderly patients.
  • Luscii: Dutch remote patient monitoring and virtual care platform used across European hospitals for chronic disease and post-discharge monitoring — closely comparable to ConCura's chronic care and teleconsultation capabilities.
  • Huma (formerly Medopad): UK-based digital health platform combining RPM, patient engagement, and AI-driven predictive analytics for hospitals and pharma — directly comparable to Qwince's adam.os + ConCura + AD-EWS stack.

Regional players

  • Exprivia: Italian IT services and healthcare technology vendor, partner of Qwince in OBIND — comparable as a domestic health-IT player providing software platforms and clinical decision support to Italian healthcare organizations.
  • Medgate: Swiss telemedicine and digital health platform offering 24/7 teleconsultations and chronic care programs — a European regional peer comparable in teleconsultation and chronic disease management scope.
  • Healthware Group: Italian digital health consultancy and technology company serving pharma and providers with digital therapeutics and engagement solutions — comparable to Qwince's pharmaceutical RWE and patient engagement focus in the Italian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Qwince social profiles

Digital presence

Qwince compliance and trust

Trust signal

Compliance4 records

Qwince financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qwince leadership team

Management profile

Number of profiles

Profiles3 records

Qwince funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qwince M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qwince

What does Qwince do?

Qwince sells a modular healthcare technology ecosystem anchored by adam.os, a software operating system that integrates clinical pathways, unifies information flows, and enables AI capabilities across heterogeneous health data sources. Built on this core platform, the company offers ConCura for patient care management and teleconsultation (a qualified medical device), Teleconsulto for secure video consultations, Puntofarma for clinical coordination across clinics, hospitals, and pharmacies, and Mercurio for multi-channel healthcare-compliant mass messaging. The company also delivers professional services for Real World Evidence generation to pharmaceutical and research partners.

Is Qwince a public or private company?

Qwince is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Qwince founded?

Qwince was founded in 2013. It employs 11 to 50 people.

Where is Qwince based?

Qwince is headquartered in Palermo, Italy, in the Europe region.

How does Qwince make money?

Four revenue lines are on record. Software Platform Subscriptions are the primary driver. The others are mercurio Messaging Platform, real World Evidence Services and professional Healthcare Services.

Who are Qwince's main competitors?

Broad incumbents on record are Doctolib, Teladoc Health and Docplanner / MioDottore. Direct peers are AiCure, Doccla, Luscii and Huma (formerly Medopad). Regional players are Exprivia, Medgate and Healthware Group.

Does Qwince have an API?

No public API is recorded for Qwince.

What industry is Qwince in?

Qwince's product category is Healthcare Technology Platforms. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales